Bill > SB200

This bill amends sections of the Alabama code related to the Prescription Drug Monitoring Program. Key provisions include: 1) Revising definitions to clarify who is considered a "pharmacist" and "practitioner" authorized to access the controlled substances database. 2) Creating a Controlled Substances Prescription Database Advisory Committee and an Information Release Review Committee to advise on the database's operations and approve requests for data access. 3) Expanding the list of entities and individuals, such as certain healthcare providers and law enforcement, who can access the controlled substances database within specified limitations. 4) Allowing the department to release or publish de-identified aggregate data from the database for statistical, research, or educational purposes with approval from the review committee. 5) Clarifying that the information in the controlled substances database is privileged and confidential, not a public record, and can only be used for investigatory, regulatory, prescribing/dispensing, or bona fide research purposes.

Health and Social Services